Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)

China flag China · Delayed Price · Currency is CNY
14.49
+0.31 (2.19%)
May 13, 2025, 2:45 PM CST
-24.92%
Market Cap 23.69B
Revenue (ttm) 6.35B
Net Income (ttm) -702.49M
Shares Out 1.67B
EPS (ttm) -0.42
PE Ratio n/a
Forward PE 16.33
Dividend 0.30 (2.12%)
Ex-Dividend Date Jul 19, 2024
Volume 19,118,067
Average Volume 10,943,903
Open 13.85
Previous Close 14.18
Day's Range 13.85 - 14.58
52-Week Range 12.41 - 20.08
Beta 0.63
RSI 67.26
Earnings Date Apr 29, 2025

About SHE:002603

Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for respiratory health, cardiovascular disease, diabetes mellitus, oncology, urologic disease, sleep-improving, and anti-aging. The company also provides dietary supplements, health food and drinks, disinfection products, and personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China. [Read more]

Sector Healthcare
Founded 1992
Employees 11,708
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002603
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.